Learn how tirzepatide works as a dual GIP and GLP‑1 receptor agonist, why it’s different from traditional GLP‑1 drugs, and what clinical trials like SURMOUNT‑1 and SURPASS show for weight loss and type 2 diabetes control.
- admin@condrug.com
- Mon - Sat: 8.00 am - 7.00 pm
We develop solutions for your clinical data needs